Charles B. Nemeroff, MD, PhD, is a consultant for ANeuroTech (division of Anima BV), Sage Therapeutics, Signant Health, Intra-Cellular Therapies, Inc., Sage Therapeutics, BioXcel Therapeutics, Silo Pharma, Engrail Therapeutics, Relmada Therapeutics, EmbarkNeuro, GoodCap Pharmaceuticals, Inc., Senseye, Inc., Pasithea Therapeutics Corp., SynapseBio, Inc., Clexio Biosciences Ltd., Ninnion, LLC., MAPS Public Benefit Corporation, Precisement Health, Lucy, EcoR1 and Galen.

He is a stock shareholder